Vext Science, Inc.
VEXT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.79% | 21.13% | 10.96% | -8.27% | -7.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.79% | 21.13% | 10.96% | -8.27% | -7.91% |
| Cost of Revenue | 31.55% | 23.02% | -5.21% | 5.45% | 60.04% |
| Gross Profit | 70.81% | 14.50% | 41.49% | -41.79% | -71.63% |
| SG&A Expenses | -12.22% | -62.14% | 11.65% | 234.65% | -8.05% |
| Depreciation & Amortization | 8.23% | 7.92% | 22.83% | 110.62% | 83.40% |
| Other Operating Expenses | -- | 37,500.00% | -- | -- | -- |
| Total Operating Expenses | 17.46% | -16.25% | 4.71% | 43.31% | 40.24% |
| Operating Income | 35.23% | 57.34% | 24.79% | -650.34% | -494.79% |
| Income Before Tax | 46.70% | -190.63% | 5.75% | -645.92% | -524.90% |
| Income Tax Expenses | 34.45% | -12.60% | 77.56% | 88.85% | 70.16% |
| Earnings from Continuing Operations | 47.36% | -263.73% | -35.83% | -919.79% | -8,764.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 47.36% | -263.73% | -35.83% | -919.79% | -8,764.02% |
| EBIT | 35.23% | 57.34% | 24.79% | -650.34% | -494.79% |
| EBITDA | 307.79% | 107.94% | 270.80% | -101.98% | -86.72% |
| EPS Basic | 51.96% | -238.29% | 17.07% | -597.22% | -5,720.00% |
| Normalized Basic EPS | 18.97% | 2.62% | 52.63% | -360.00% | -728.57% |
| EPS Diluted | 55.00% | -238.29% | 17.07% | -597.22% | -6,100.00% |
| Normalized Diluted EPS | 18.97% | 2.11% | 53.51% | -360.00% | -728.57% |
| Average Basic Shares Outstanding | 9.93% | 18.32% | 63.95% | 63.93% | 50.57% |
| Average Diluted Shares Outstanding | 9.82% | 17.75% | 66.03% | 63.53% | 50.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |